Spots Global Cancer Trial Database for brain tumor, pediatric
Every month we try and update this database with for brain tumor, pediatric cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors | NCT04738162 | Brain Tumor, Pe... | 5-Aminolevulini... | 3 Years - 17 Years | Universität Münster | |
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours | NCT05553899 | Brain Tumor, Pe... | PET-MRI | 8 Years - 18 Years | Sheffield Children's NHS Foundation Trust | |
Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing | NCT04722237 | Brain Tumors Quality of Life Brain Tumor, Pe... | Acceptance and ... | 11 Years - 24 Years | Nottingham University Hospitals NHS Trust | |
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients | NCT06309251 | Drug Resistant ... Autism Spectrum... Chronic Migrain... Brain Tumor, Pe... | ketogenic diet ... | - 18 Years | Danone Nutricia SpA Società Benefit | |
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer | NCT03936465 | Solid Tumor, Ch... Lymphoma Brain Tumor, Pe... | BMS-986158 BMS-986378 | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors | NCT04019470 | Brain Tumor, Pe... | 3 Years - 18 Years | Capital Medical University | ||
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China | NCT05672043 | Medulloblastoma Central Nervous... Ependymoma Germ Cell Tumor Glioma Brain Tumor, Pe... | 0 Years - 18 Years | Beijing Tiantan Hospital | ||
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients | NCT05709522 | Brain Tumor, Pe... Blood Cancer | Neurocognitive ... | 5 Years - 21 Years | Aga Khan University | |
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors | NCT05169944 | Brain Cancer Malignant Brain... Recurrent Brain... Progressive Mal... Brain Tumor, Pe... Brain Tumor Adu... | Magrolimab | 3 Years - | University of California, San Francisco | |
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours | NCT05553899 | Brain Tumor, Pe... | PET-MRI | 8 Years - 18 Years | Sheffield Children's NHS Foundation Trust | |
Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing | NCT04722237 | Brain Tumors Quality of Life Brain Tumor, Pe... | Acceptance and ... | 11 Years - 24 Years | Nottingham University Hospitals NHS Trust | |
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors | NCT04019470 | Brain Tumor, Pe... | 3 Years - 18 Years | Capital Medical University | ||
RE-irradiation of Diffuse MIdline Glioma paTients | NCT06093165 | Diffuse Midline... Diffuse Intrins... Diffuse Glioma Pontine Tumors Thalamic Tumor Brain Tumor, Pe... | Re-irradiation | 12 Months - 21 Years | Rigshospitalet, Denmark | |
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients | NCT05709522 | Brain Tumor, Pe... Blood Cancer | Neurocognitive ... | 5 Years - 21 Years | Aga Khan University | |
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors | NCT05169944 | Brain Cancer Malignant Brain... Recurrent Brain... Progressive Mal... Brain Tumor, Pe... Brain Tumor Adu... | Magrolimab | 3 Years - | University of California, San Francisco |